182 related articles for article (PubMed ID: 26178530)
1. High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.
Dent BM; Ogle LF; O'Donnell RL; Hayes N; Malik U; Curtin NJ; Boddy AV; Plummer ER; Edmondson RJ; Reeves HL; May FE; Jamieson D
Int J Cancer; 2016 Jan; 138(1):206-16. PubMed ID: 26178530
[TBL] [Abstract][Full Text] [Related]
2. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
[TBL] [Abstract][Full Text] [Related]
3. Circulating epithelial cells in patients with thyroid carcinoma. Can they be identified in the blood?
Winkens T; Pachmann K; Freesmeyer M
Nuklearmedizin; 2013; 52(1):7-13. PubMed ID: 23254889
[TBL] [Abstract][Full Text] [Related]
4. Detection of Abundant Non-Haematopoietic Circulating Cancer-Related Cells in Patients with Advanced Epithelial Ovarian Cancer.
Kumar J; Chudasama D; Roberts C; Kubista M; Sjöback R; Chatterjee J; Anikin V; Karteris E; Hall M
Cells; 2019 Jul; 8(7):. PubMed ID: 31319587
[No Abstract] [Full Text] [Related]
5. Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
Ogle LF; Orr JG; Willoughby CE; Hutton C; McPherson S; Plummer R; Boddy AV; Curtin NJ; Jamieson D; Reeves HL
J Hepatol; 2016 Aug; 65(2):305-13. PubMed ID: 27132171
[TBL] [Abstract][Full Text] [Related]
6. Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia.
Willms A; Müller C; Julich H; Klein N; Schwab R; Güsgen C; Richardsen I; Schaaf S; Krawczyk M; Krawczyk M; Lammert F; Schuppan D; Lukacs-Kornek V; Kornek M
Oncotarget; 2016 May; 7(21):30867-75. PubMed ID: 27127176
[TBL] [Abstract][Full Text] [Related]
7. Determining tissue origin of circulating epithelial cells (CEC) in patients with differentiated thyroid cancer by real-time PCR using thyroid mRNA probes.
Sorg S; Pachmann K; Brede-Hekimian K; Freesmeyer M; Winkens T
Cancer Lett; 2015 Jan; 356(2 Pt B):491-5. PubMed ID: 25304372
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of circulating tumour cells expressing CD44 variants in the blood of gastric cancer patients by flow cytometry.
Pituch-Noworolska A; Wieckiewicz J; Krzeszowiak A; Stachura J; Ruggiero I; Gawlicka M; Szczepanik A; Karcz D; Popiela T; Zembala M
Anticancer Res; 1998; 18(5B):3747-52. PubMed ID: 9854488
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumour cells as biomarkers for evaluating cryosurgery on unresectable hepatocellular carcinoma.
Shi J; Li Y; Liang S; Zeng J; Liu G; Mu F; Li H; Chen J; Lin M; Sheng S; Zhang H; Liu T; Niu L
Oncol Rep; 2016 Oct; 36(4):1845-51. PubMed ID: 27573435
[TBL] [Abstract][Full Text] [Related]
10. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
[TBL] [Abstract][Full Text] [Related]
11. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
[TBL] [Abstract][Full Text] [Related]
12. A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells.
Lin HC; Hsu HC; Hsieh CH; Wang HM; Huang CY; Wu MH; Tseng CP
Clin Chim Acta; 2013 Apr; 419():77-84. PubMed ID: 23415697
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.
Catenacci DV; Chapman CG; Xu P; Koons A; Konda VJ; Siddiqui UD; Waxman I
Gastroenterology; 2015 Dec; 149(7):1794-1803.e4. PubMed ID: 26341722
[TBL] [Abstract][Full Text] [Related]
15. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
16. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.
Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S
Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424
[TBL] [Abstract][Full Text] [Related]
17. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
18. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
19. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
Zhang Y; Wang F; Ning N; Chen Q; Yang Z; Guo Y; Xu D; Zhang D; Zhan T; Cui W
Int J Cancer; 2015 Mar; 136(5):1228-33. PubMed ID: 25042121
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
